Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02261909

New Prognostic Kidney Function Markers in Emergency Patients New Markers of Kidney Function in ED Patients

New Prognostic Kidney Function Markers in Emergency Patients

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Krankenhaus Barmherzige Brüder, Regensburg · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

NephroCheck is measuring the concentration of a certain protein combination in the urine of patients. In elevated values there is a probability of renal failure (already proven in intensive care patients). The investigators would like to investigate whether the investigators can predict renal failure in patients receiving contrast enhanced CT's in the emergency department. That would lead to an earlier nephrologist consult in those patients.

Detailed description

The use of contrast agents can - especially in already in impaired renal function - lead to a decline in real function. The contrast enhanced CT is especially in emergency patients an important diagnostic tool for example in the detection of pulmonary embolism or mesenteric ischemia. Creatinine has been used as a marker for real function so far. But the investigators all know that creatinine is not a perfect marker especially as it is influenced by age, sex, weight and muscle mass. Especially in the diagnosis of acute renal failure creatinine does not allow and recent change in the kidney function. This prospective, unicentric study should therefore investigate two new markers in emergency patients who need an emergency contrast enhanced CT to early predict pending kidney function decline.

Conditions

Timeline

Start date
2015-05-01
Primary completion
2016-05-01
Completion
2016-06-01
First posted
2014-10-10
Last updated
2022-08-22

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02261909. Inclusion in this directory is not an endorsement.

New Prognostic Kidney Function Markers in Emergency Patients New Markers of Kidney Function in ED Patients (NCT02261909) · Clinical Trials Directory